Personalis Lands $50M Merck Investment, Extends Key Moderna Partnership for Cancer Therapy Platform
Personalis (NASDAQ: PSNL) announced two significant agreements: a $50 million investment from Merck through private...
Personalis (NASDAQ: PSNL) announced two significant agreements: a $50 million investment from Merck through private...
Listen to this article Kenton Tsoodle The 2024-25 Thunder season kicks off this Thursday, with the first home game on...